Association of adrenal metastases with outcomes in patients with metastatic clear cell renal cell carcinoma (mccRCC) treated with nivolumab in the GETUG-AFU-26 NIVOREN phase II trial.

被引：0
|
作者：
Billon, Emilien
Dalban, Cecile
Oudard, Stephane
Chevreau, Christine
Laguerre, Brigitte
Barthelemy, Philippe
Borchiellini, Delphine
Geoffrois, Lionnel
Negrier, Sylvie
Joly, Florence
Thiery-Vuillemin, Antoine
Gross-Goupil, Marine
Rolland, Frederic
Priou, Frank
Mahammedi, Hakim
Tantot, Florence
Escudier, Bernard
Chabaud, Sylvie
Albiges, Laurence
Gravis, Gwenaelle
机构：
[1] Inst Paoli Calmettes, Marseille, France
[2] Ctr Leon Berard, Lyon, France
[3] Hop Europeen Georges Pompidou, Paris, France
[4] IUCT Oncopole Inst Claudius Regaud, Toulouse, France
[5] Ctr Eugene Marquis, Rennes, France
[6] Inst Cancerol Strasbourg Europe, Strasbourg, France
[7] Univ Cote dAzur, Ctr Antoine Lacassagne, Nice, France
[8] Ctr Alexis Vautrin, Inst Cancerol Lorraine, Vandoeuvre Les Nancy, France
[9] Univ Lyon 1, Ctr Leon Berard, Dept Med Oncol, Lyon, France
[10] Ctr Francois Baclesse, Dept Med Oncol, Caen, France
[11] Univ Hosp Jean Minjoz, Besancon, France
[12] CHU Bordeaux, Hop St Andre, Bordeaux, France
[13] Inst Cancerol Ouest, Dept Med Oncol, St Herblain, France
[14] CHD Vendee Hop Oudairies, La Roche Sur Yon, France
[15] Ctr Jean Perrin, Clermont Ferrand, France
[16] UNICANCER, GETUG Grp, Paris, France
[17] Gustave Roussy, Villejuif, France
[18] Univ Paris Saclay, Gustave Roussy Canc Campus, Villejuif, France
[19] Aix Mareseille Univ, Inst Paoli Calmettes, Marseille, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 06期
关键词：
D O I：
10.1200/JCO.2022.40.6_suppl.348
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
348
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Brain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial
    Flippot, R.
    Dalban, C.
    Laguerre, B.
    Borchiellini, D.
    Gravis, G.
    Negrier, S.
    Chevreau, C. M.
    Joly, F.
    Geoffrois, L.
    Ladoire, S.
    Mahammedi, H.
    Tantot, F.
    Escudier, B.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2018, 29 : 306 - 306
  • [12] NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab
    Ajuria, L. Carril
    Naigeon, M.
    Dalban, C.
    Desnoyer, A.
    Rioux-Leclercq, N.
    Sautes-Fridman, C.
    Meylan, M.
    Vano, Y.
    Beuselinck, B.
    Chouaib, S.
    de Oliveira, C.
    Tantot, F.
    Escudier, B.
    Albiges, L.
    Chaput, N.
    ANNALS OF ONCOLOGY, 2021, 32 : S704 - S705
  • [13] The impact of baseline peripheral cytokines on survival in metastatic clear cell renal cell carcinoma (RCC) treated with nivolumab: NIVOREN GETUG-AFU 26 Translational study.
    Carril, Lucia
    Naigeon, Marie
    Dalban, Cecile
    Desnoyer, Aude
    Rioux-Leclercq, Nathalie
    Sautes-Fridman, Catherine
    Meylan, Maxime
    Vano, Yann-Alexandre
    Beusenlick, Benoit
    Chouaib, Salem
    de Oliveira, Caroline
    Tantot, Florence
    Escudier, Bernard
    Albiges, Laurence
    Chaput, Nathalie
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [14] Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study
    Velev, Maud
    Dalban, Cecile
    Chevreau, Christine
    Gravis, Gwenaelle
    Negrier, Sylvie
    Laguerre, Brigitte
    Gross-Goupil, Marine
    Ladoire, Sylvain
    Borchiellini, Delphine
    Geoffrois, Lionnel
    Joly, Florence
    Priou, Frank
    Barthelemy, Philippe
    Laramas, Mathieu
    Narciso, Berangere
    Thiery-Vuillemin, Antoine
    Berdah, Jean-Francois
    Ferrari, Victoria
    Thomas, Quentin Dominique
    Mione, Cecile
    Curcio, Hubert
    Oudard, Stephane
    Tantot, Florence
    Escudier, Bernard
    Chabaud, Sylvie
    Albiges, Laurence
    Thibault, Constance
    EUROPEAN JOURNAL OF CANCER, 2023, 182 : 66 - 76
  • [15] Impact of First Line Antiangiogenic Therapy Duration on Nivolumab Outcome in Metastatic Renal Cell Carcinoma Patients Treated in the GETUG-AFU 26 NIVOREN
    Guilhem-Ducleon, Guillemette
    Dalban, Cecile
    Negrier, Sylvie
    Gravis, Gwenaelle
    Laguerre, Brigitte
    Chevreau, Christine
    Oudard, Stephane
    Barthelemy, Philippe
    Ladoire, Sylvain
    Boughalem, Elouen
    Borchiellini, Delphine
    Linassier, Claude
    Nenan, Soazig
    Flippot, Ronan
    Albiges, Laurence
    Goupil, Marine Gross
    CLINICAL GENITOURINARY CANCER, 2023, 21 (06) : 643 - 652
  • [16] Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study
    Flippot, Ronan
    Dalban, Cecile
    Laguerre, Brigitte
    Borchiellini, Delphine
    Gravis, Gwenaelle
    Negrier, Sylvie
    Chevreau, Christine
    Joly, Florence
    Geoffrois, Lionnel
    Ladoire, Sylvain
    Mahammedi, Hakim
    Rolland, Frederic
    Gross-Goupil, Marine
    Deluche, Elise
    Priou, Frank
    Laramas, Mathieu
    Barthelemy, Philippe
    Narciso, Berengere
    Houede, Nadine
    Culine, Stephane
    Oudard, Stephane
    Chenot, Marina
    Tantot, Florence
    Chabaud, Sylvie
    Escudier, Bernard
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (23) : 2008 - +
  • [17] NIVOREN GETUG-AFU 26 translational study: CD8 infiltration and PD-L1 expression are associated with outcome in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) treated with nivolumab (N)
    Vano, Y.
    Rioux-Leclercq, N.
    Dalban, C.
    Sautes-Fridman, C.
    Bougouin, A.
    Chaput, N.
    Chouaib, S.
    Beuselinck, B.
    Chevreau, C. M.
    Gross-Goupil, M.
    Negrier, S.
    Laguerre, B.
    Borchiellini, D.
    Colina-Moreno, I.
    Fridman, W. H.
    Chabaud, S.
    Tantot, F.
    Monteiro, J. Barros
    Escudier, B.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2019, 30 : 360 - +
  • [18] Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma (mRCC) and brain metastases: Preliminary results from the GETUG-AFU 26 (Nivoren) study.
    Escudier, Bernard J.
    Chabaud, Sylvie
    Borchiellini, Delphine
    Gravis, Gwenaelle
    Chevreau, Christine
    Brachet, Pierre Emmanuel
    Geoffrois, Lionnel
    Laguerre, Brigitte
    Mahammedi, Hakim
    Negrier, Sylvie
    Rolland, Frederic
    Goupil, Marine Gross
    Habibian, Muriel
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [19] Is body mass index (BMI) associated with favorable outcomes in metastatic renal cell carcinoma (mRCC) treated with nivolumab? An ancillary study of the NIVOREN-GETUG AFU-26 trial
    Colomba, Emeline
    Dalban, Cecile
    Flechon, Aude
    Chevreau, Christine
    Gravis, Gwenaelle
    Thibault, Constance
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Goupil, Marine Gross
    Geoffrois, Lionnel
    Rolland, Frederic
    Thiery-Vuillemin, Antoine
    Joly, Florence
    Ladoire, Sylvain
    Tantot, Florence
    Escudier, Bernard
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [20] Safety and efficacy of nivolumab in metastatic renal cell carcinoma (mRCC): Results from the NIVOREN GETUG-AFU 26 study.
    Albiges, Laurence
    Negrier, Sylvie
    Dalban, Cecile
    Gravis, Gwenaelle
    Chevreau, Christine
    Oudard, Stephane
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Gross-Goupil, Marine
    Geoffrois, Lionnel
    Brihoum, Meryem
    Escudier, Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
12345